Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    Open Studies | "Mucocutaneous Lymph Node Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Mucocutaneous Lymph Node Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Etanercept in Kawasaki Disease
Conditions: Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions: Drug: Etanercept;   Drug: Placebo
2 Recruiting Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012
Condition: Kawasaki Disease
Intervention:
3 Recruiting Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial
Condition: Kawasaki Disease
Interventions: Drug: Infliximab;   Drug: IVIG
4 Unknown  Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Other: Cardiac evaluation
5 Recruiting Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: Anakinra
6 Recruiting Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease
Conditions: Kawasaki Disease;   Aneurysm, Coronary
Intervention: Drug: Atorvastatin
7 Recruiting Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities
Condition: Kawasaki Disease
Intervention: Drug: Atorvastatin
8 Recruiting Etiology Study of Kawasaki Disease
Condition: Kawasaki Disease
Intervention:
9 Not yet recruiting Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
Conditions: Kawasaki Disease;   Coronary Aneurysm
Interventions: Drug: Doxycycline;   Drug: Standard care

Indicates status has not been verified in more than two years